We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of Advanced Soft Tissue Sarcomas with a Modified CYVADIC Protocol.
- Authors
Pfeffer, Raphael; Sulkes, Aaron; Biran, Shoshana
- Abstract
33 consecutive patients with metastatic or locally recurrent soft tissue sarcoma were treated with a modification of the CYVADIC (cyclophosphamide, vincristine, Adriamycin, dacarbazine) protocol. In an attempt to enhance the response rate without increasing the toxicity, the dose of Adriamycin was raised to 60 mg/m2 and the dose of cyclophosphamide to 600 mg/m2 in each cycle. The dose of dacarbazine was decreased to 150 mg/m2/day for 5 days. Of 31 evaluable patients there were 4 complete responses (13%) and 9 partial responses for a total response rate of 39%. 11 patients (33%) had minimal response or stable disease. The response achieved with our dose modification was no better than that achieved in several series with conventionally dosed CYVADIC. Copyright © 1984 S. Karger AG, Basel
- Publication
Oncology, 1984, Vol 41, Issue 5, p308
- ISSN
0030-2414
- Publication type
Article
- DOI
10.1159/000225845